PTGER4 and neoplasm: In a mouse model of MBC, the novel small-molecule EP4 antagonist (RQ-15986) effectively blocks the immunosuppressive effects of PGE2 on NK cells, thereby enhancing NK cell function and inhibiting tumor growth and metastasis 166.